Variations and determinants of antibiotic consumption in Hungarian adult intensive care units

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 1, 2012, Pages 104-109

  Benko, Ria ^a   Matuz, Mária ^a   Peto, Zoltán ^a   Bogár, Lajos ^b   Viola, Réka ^a   Doró, Péter ^a   Soós, Gyöngyvér ^a   Hajdú, Edit ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Adult intensive care units; Antibiotic use; DDD per 100 patient days; Determinants of use

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAMASE INHIBITOR; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; IMIDAZOLE DERIVATIVE; LINCOSAMIDE; MACROLIDE; PENICILLIN G; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TRIMETHOPRIM;

ADULT; ARTICLE; DRUG USE; HEALTH CARE POLICY; HOSPITAL DEPARTMENT; HOSPITAL PHARMACY; HUMAN; HUNGARY; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADULT; ANTI-BACTERIAL AGENTS; HUMANS; HUNGARY; INTENSIVE CARE; INTENSIVE CARE UNITS; ORGANIZATIONAL POLICY; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84855352284     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.2192     Document Type: Article

References (34)

1. Levy SB. Antibiotic resistance: Consequences of inaction. Clin Infect Dis 2001; 33: S124-S129.
2. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134: 298-314.
3. Chastre J. Evolving problems with resistant pathogens. Clin Microbiol Infect 2008; 14: 3-14.
4. Walther SM, Erlandsson M, Burman LG, et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of swedish intensive care units. Acta Anaesthesiol Scand 2002; 46: 1075-1081.
5. Gandhi TN, DePestel DD, Collins CD, Nagel J, Washer LL. Managing antimicrobial resistance in intensive care units. Crit Care Med 2010; 38: S315-S323. doi: 10.1097/CCM.0b013e3181e6a2a4
6. Lawrence KL, Kollef MH. Antimicrobial Stewardship in the Intensive Care Unit Advances and Obstacles. Am J Respir Crit Care Med 2009; 179: 434-438. doi: 10.1164/rccm.200809-1394CP
7. Bandi D, Gog B, Kiss B, Somoracz G, Jakics J. Policy in antibiotics-therapy and its results in our hospital. Antibiotikumpolitika és eredményei kórházunkban 1992; 36: 459-464.
8. Katona Z, Matejka Z, Mikola B. Examination of antibacterial therapy in the hospitals of Bacs-Kiskun County. Antibakteriális kezelés egy megye kórházaiban 1987; 128: 2631-2633.
9. Benko R, Matuz M, Hajdu E, et al. The participation of pharmacist in antibiotic related activities of Hungarian hospitals and intensive care units. Acta Pharm Hung 2009; 79: 57-62.
10. Hajdu E, Benko R, Matuz M, et al. Microbiological service for intensive care units in Hungary. Orv Hetil 2009; 150: 1037-1042. doi: 10.1556/OH.2009.28592
11. WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs 2008. 2008.
12. Kuster SP, Ruef C, Bollinger AK, et al. Correlation between case mix index and antibiotic use in hospitals. J Antimicrob Chemother 2008; 62: 837-842. doi: 10.1093/jac/dkn275
13. Hanberger H, Arman D, Gill H, et al. Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control. Intensive Care Med 2009; 35: 91-100. doi: 10.1007/s00134-008-1237-y
14. Meyer E, Schwab F, Schroeren-Boersch B, Ruden H, Gastmeier P. Diversity in antibiotic use in intensive care units in Germany. Dtsch Med Wochenschr 2008; 133: 235-240. doi: 10.1055/s-2008-1017502
15. Dumartin C, L'Heriteau F, Pefau M, et al. Antibiotic use in 530 French hospitals: results from a surveillance network at hospital and ward levels in 2007. J Antimicrob Chemother 2010; 65: 2028-2036. doi: 10.1093/jac/dkq228
16. Kuster SP, Ruef C, Ledergerber B, et al. Quantitative Antibiotic Use in Hospitals: Comparison of Measurements, Literature Review, and Recommendations for a Standard of Reporting. Infection 2008; 36: 549-559. doi: 10.1007/s15010-008-7462-z
17. Kern WV, de With K, Steib-Bauert M, et al. Antibiotic use in non-university regional acute care general hospitals in southwestern Germany, 2001-2002. Infection 2005; 33: 333-339. doi: 10.1007/s15010-005-5059-3
18. Meyer E, Schwab F, Gastmeier P, Rueden H, Daschner FD. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 2006; 34: 303-309. doi: 10.1007/s15010-006-6619-x
19. de With K, Meyer E, Steib-Bauert M, Schwab F, Daschner FD, Kern WV. Antibiotic use in two cohorts of German intensive care units. J Hosp Infect 2006; 64: 231-237. doi: 10.1016/j.jhin.2006.05.018
20. Erlandsson M, Burman LG, Cars O, et al. Prescription of antibiotic agents in Swedish intensive care units is empiric and precise. Scand J Infect Dis 2007; 39: 63-69. doi: 10.1080/00365540600740504
21. Hanberger H, Erlandsson M, Burman LG, et al. High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility. Scand J Infect Dis 2004; 36: 24-30.
22. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA 1996; 275: 234-240.
23. Filius PM, Liem TB, van der Linden PD, et al. An additional measure for quantifying antibiotic use in hospitals. J Antimicrob Chemother 2005; 55: 805-808. doi: 10.1093/jac/dki093
24. Meyer E, Buttler J, Schneider C, et al. Modified guidelines impact on antibiotic use and costs: duration of treatment for pneumonia in a neurosurgical ICU is reduced. J Antimicrob Chemother 2007; 59: 1148-1154. doi: 10.1093/jac/dkm088
25. Peto Z, Benko R, Matuz M, Csullog E, Molnar A, Hajdu E. Results of a Local Antibiotic Management Program on Antibiotic Use in a Tertiary Intensive Care Unit in Hungary. Infection 2008; 36: 560-564. doi: 10.1007/s15010-008-7377-8
26. MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev 2005; 18: 638-656.
27. Ramsay C, Brown E, Hartman G, Davey P. Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing. J Antimicrob Chemother 2003; 52: 764-771. doi: 10.1093/jac/dkg460
28. Meyer E, Lapatschek M, Bechtold A, Schwarzkopf G, Gastmeier P, Schwab F. Impact of restriction of third generation cephalosporins on the burden of third generation cephalosporin resistant K. pneumoniae and E. coli in an ICU. Intensive Care Med 2008; 35: 862-870. doi: 10.1007/s00134-008-1355-6
29. Mol PG, Wieringa JE, Nannanpanday PV, et al. Improving compliance with hospital antibiotic guidelines: a time-series intervention analysis. J Antimicrob Chemother 2005; 55: 550-557. doi: 10.1093/jac/dki037
30. Liem TB, Krediet TG, Fleer A, Egberts TC, Rademaker CM. Variation in antibiotic use in neonatal intensive care units in the Netherlands. J Antimicrob Chemother 2010; 65: 1270-1275. doi: 10.1093/jac/dkq107
31. Loeffler JM, Garbino J, Lew D, Harbarth S, Rohner P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 2003; 35: 843-850.
32. Healy DP, Brodbeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother 1996; 40: 6-10.
33. Pinder M, Bellomo R, Lipman J. Pharmacological principles of antibiotic prescription in the critically ill. Anaesth Intensive Care 2002; 30: 134-144.
34. Hanberger H, Burman LG, Cars O, et al. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Acta Anaesthesiol Scand 2007; 51: 937-941. doi: 10.1111/j.1399-6576.2007.01364.x